MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 14.54

Change

+0.05 (+0.37)%

Market Cap

USD 0.48B

Volume

1.29K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.33 (+0.71%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.60 (+0.28%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.02 (+0.25%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

+0.13 (+0.35%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.65 (+0.53%)

USD 8.92B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.31 (+0.53%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.20 (+0.33%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

+0.16 (+0.28%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.31%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.51 (+0.31%)

USD 5.39B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.49% 89% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.49% 89% A- 80% B-
Trailing 12 Months  
Capital Gain 14.16% 57% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.16% 54% F 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.66% 57% F 62% D
Dividend Return 9.66% 55% F 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.00% 75% C 88% B+
Risk Adjusted Return 120.80% 93% A 97% N/A
Market Capitalization 0.48B 65% D 69% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike